Clinical Trials Browser

INDUSTRY × Triple Negative Breast Neoplasms × afuresertib × Clear all

NCT05390710 2024-10-10

PhI to Solid Tumors and PhII to Locally Advanced or mTNBC

Phase 1 Completed

Triple Negative Breast Neoplasms